This is the text extract for September Tender Notification., browse documents here.

---

30 September 2010

TENDER RESULTS

The PHARMAC Board (or Chief Executive under delegated authority) has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2009/10 Invitation to Tender, dated 4 December 2009. Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted. Notification of Product Changes (NOPC) forms Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm 12th October 2010. More information and NOPC forms can be found on our website – www.pharmac.govt.nz/schedule.asp. 2009/10 Tender Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 1. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing (or subsidy reduction) for tender winning brand at the tender subsidy will occur on 1 November 2010; reference pricing of non-tender winning brands will occur on 1 January 2011; Sole Subsidised Supply commences on 1 April 2011; delisting of other brands in Section B will occur on 1 April 2011.

The decisions were as follows:

Chemical Name

Presentation; Pack size and type Tab 12.5 mg; 100 tablets, bottle Tab 25 mg; 100 tablets, bottle Tab 50 mg; 100 tablets, bottle Tab (BPC cap strength); 1,000 tablets, bottle

Current subsidy and price $10.40 (500 pack) $13.40 (500 pack) $19.00 (500 pack) $10.85 (MultiADE) $14.80 (Healtheries)

New subsidy and price $2.00

Sole Supply Brand (Supplier) m-Captopril (Multichem) m-Captopril (Multichem) m-Captopril (Multichem) MultiADE (Boucher and Muir)

Brand (Supplier) affected by reference pricing and delisting Apo-Captopril (Apotex)

Captopril

Captopril

$2.40

Apo-Captopril (Apotex)

Captopril

$3.50

Apo-Captopril (Apotex) Healtheries Multi-vitamin tablets (Healtheries)

Vitamins

$8.00

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 2. Tenders awarded to listed pharmaceuticals where an alternative brand is already listed – price change for the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 November 2010; Hospital Supply Status and DV Limits will apply from 1 January 2011; delisting of other brands in Section H will occur on 1 January 2011.

A351403 - qA15909

---

The decisions were as follows:

Chemical Name Captopril

Presentation; Pack size and type Tab 12.5 mg; 100 tablets, bottle Tab 25 mg; 100 tablets, bottle Tab 50 mg; 100 tablets, bottle

Hospital Supply Brand (Supplier) m-Captopril (Multichem) m-Captopril (Multichem) m-Captopril (Multichem)

Current pack price

$10.40 (500 pack) $13.40 (500 pack) $19.00 (500 pack)

New pack price $2.00

DV Limit 1%

Brand (Supplier) to be delisted Apo-Captopril (Apotex) Apo-Captopril (Apotex) Apo-Captopril (Apotex)

Captopril

$2.40

1%

Captopril

$3.50

1%

3. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 November 2010 and Hospital Supply Status and DV Limits will apply from 1 January 2011.

The decisions were as follows:

Chemical Name Bacillus calmette-guerin (BCG) vaccine*

Presentation; Pack size and type Inj 2-8 x 100 million CFU; 1 injection, vial

Hospital Supply Brand (Supplier) OncoTICE (Merck Sharpe & Dohme)

Pack Price $187.37

DV Limit 1%

* BCG vaccine will be listed in Section B of the Pharmaceutical Schedule as “PCT only – Specialist” from 1 November 2010 and is subsidised only for bladder cancer

Products where no tender is to be awarded for Sole Subsidised Supply or Hospital Supply Status The PHARMAC Board (or Chief Executive under delegated authority) resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2008/09 Invitation to Tender, dated 23 December 2008:

Chemical Name Desmopressin Desmopressin Line Item Tab 100 mcg Tab 200 mcg

The PHARMAC Board (or Chief Executive under delegated authority) resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2009/10 Invitation to Tender, dated 4 December 2009:

Chemical Name Metoclopramide Tenoxicam Salicylic acid Dobutamine Line Item Tab 10 mg Tab 20 mg Powder Inj 12.5 mg per ml, 20 ml

For products included in the 2008/09 Invitation to Tender and 2010/11 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or Chief Executive) approval. We will keep you informed of any updates regarding such tender products as decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A351403 - qA15909

Page 2 of 2